Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma

The development of targeted molecular therapies has greatly benefited patients with lung adenocarcinomas. In contrast, these treatments have had little benefit in the management of lung squamous cell carcinoma (lung SCC). Therefore, new treatment options based on current genomic approaches are neede...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumamoto, Tomohiro, Seki, Naohiko, Mataki, Hiroko, Mizuno, Keiko, Kamikawaji, Kazuto, Samukawa, Takuya, Koshizuka, Keiichi, Goto, Yusuke, Inoue, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063422/
https://www.ncbi.nlm.nih.gov/pubmed/27633630
http://dx.doi.org/10.3892/ijo.2016.3690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063422/
https://www.ncbi.nlm.nih.gov/pubmed/27633630
http://dx.doi.org/10.3892/ijo.2016.3690

Ejemplares similares